pharmaphorum

JUNE 28, 2016

In today’s competitive, highly regulated environment, product success is dependent upon data and fact-based decision making. More and more, Medical Affairs teams play a pivotal role in education pre- and post-launch, yet the explosion of big data in healthcare is changing how we make value-based decisions that are critical to success.

Compliance 52

Compliance Big Data Regulation Production 52

ACRP blog

APRIL 5, 2023

Through these collaborations, advanced technologies tied to AI and big data are being employed to develop personalized and targeted medicines, ultimately leading to more effective treatments for diseases like cancer and immune deficiencies,” Lyons notes.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

Drug Discovery World

JULY 20, 2023

The EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The use of AI is rapidly developing in society and as regulators we see more and more applications in the field of medicines.

Drugs 40

Drugs Regulation Medicine Big Data 40

pharmaphorum

JULY 4, 2022

Together, the webinar panellists explored the potential of medical informatics solutions and methods in rare disease research, studies, data optimisation, and usability to overcome these challenges, all whilst maintaining compliance with data protection regulations and a patient-centric approach.

Genome 105

Genome Genomics Research Medicine 105